Skip to main content

Table 3 Influence of age and gender on comorbidities

From: COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study

    

Age

  

Gender

 

< 30

30–45

45–60

60–75

> 75

Male

Female

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Hypertensiona

no

21 (7.8)

55 (20.4)

97 (35.9)

65 (24.1)

32 (11.9)

155 (57.4)

115 (42.6)

yes

1 (0.3)

9 (3.1)

50 (17.1)

116 (39.6)

117 (39.9)

182 (62.1)

111 (37.9)

Dyslipidaemiaa

no

22 (5.6)

59 (15.0)

117 (29.7)

108 (27.4)

88 (22.3)

227 (57.6)

167 (42.4)

yes

0 (0.0)

3 (1.9)

30 (18.9)

68 (42.8)

58 (36.5)

103 (64.8)

56 (35.2)

Diabetesa

no

21 (5.0)

58 (13.7)

128 (30.3)

114 (27.0)

101 (23.9)

241 (57.1)

181 (42.9)

yes

1 (0.8)

6 (4.6)

19 (14.5)

63 (48.1)

42 (32.1)

88 67.2)

43 (32.8)

  1. aall Chi Squared p-values either vs age or gender were < 0.001